TECH Bio-Techne Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 68
Relative Strength: Rel. Strength: 84
Relative Valuation: Rel. Valuation: 34
Relative Profitability: Rel. Profitability: 90

EPS in 2026 (TTM): $1.17

Last Report Period Date: Jun 30, 2026

As of September 2026, according to Bio-Techne's current financial statements, the company's 12-month EPS is $1.17. For the year 2026, the company recorded an earnings per share (EPS) of $1.17, which marks an increase compared to its EPS of $0.47 in 2025. Bio-Techne's earnings per share for the quarterly report ending on Jun 30, 2026 reached $0.35.

TECH earnings history

Historical annual and quarterly earnings per share (EPS) data for Bio-Techne
EPS (TTM)
$1.17
EPS Growth YoY (Quarterly)
418.2%
EPS (Quarterly)
$0.35
EPS Growth (Quarterly)
6.1%

The annual EPS for the year 2026 was $1.17, an increase of 148.9% from $0.47 in 2025. For the fiscal quarter that ended on Jun 30, 2026, the per-share earnings was $0.35, showing a 418.2% increase from the same quarter last year. For the twelve months ending June 2026, the EPS is $1.17. For the year 2025, the yearly earnings per share was $0.47, marking a decrease of 56.1% from 2024.

TECH EPS vs price chart

TECH EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
418.2%
EPS growth YoY
148.9%
EPS growth 3Y avg
-13.5%
EPS growth 5Y avg
5.2%

Bio-Techne has registered an increase in EPS of 418.2% during the last 12 months (YoY, quarterly). In the last three years, TECH recorded an average annual EPS growth rate of -13.5%. Bio-Techne had an average annual EPS growth rate of 5.2% during the last 5 years. Across the last decade, TECH had an average annual EPS growth of 5.3%.

TECH Earnings Waterfall

Breakdown of revenue, profit and net income for Bio-Techne

TECH Earnings vs Peers

What are the earnings of TECH compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
QGEN Qiagen NV 22.02 415.8% 1.8% 3.9%
TMO Thermo Fisher Scientific Inc 32.75 7.2% 0% 2%
DHR Danaher Corp 35.42 -4.9% -19.7% 0.4%
GE General Electric Company 37.85 35.8% 447.4% 12.1%
BIO Bio-Rad Laboratories Inc - Class A 45.88 142.6% N/A -26.3%
BDX Becton Dickinson & Company 53.57 -0.9% -0.6% 16.2%
TECH Bio-Techne Corp 61.64 148.9% -13.5% 5.2%
STEM Stem Inc N/A 115.6% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.